Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 25g

ethyl 3-[(2,2-diethoxyethyl)amino]propanoate, 95.0%, 10g

3-Amino-3-(4-fluoro-3-nitrophenyl)propanoic acid, 95.0%, 1g

(5-Bromo-2-methylphenyl)hydrazine hydrochloride, 97%, 1g

3-((Benzyloxy)carbonyl)-2-methylthiazolidine-4-carboxylic acid, 98%, 5g

(S)-3-Amino-4-(4-(trifluoromethyl)phenyl)butanoic acid hydrochloride, 95.0%, 1g

(4-Amino-3-bromophenyl)acetonitrile, 97.0%, 1g

2-(3,4-Epoxycyclohexyl)ethyltrimethoxysilane>97.0%(GC)25mL

2-[(4,5-Dihydro-1H-imidazol-2-yl)amino]ethan-1-ol hydroiodide, 80.0%, 5g

2-(Ethylsulfonyl)aniline, 95.0%, 250mg

1,2,5-Trimethyl-pyrrolidine-2,5-dicarboxylic acid, 95.0%, 5g

4-Chloro-3-iodo-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg

(4-(Piperidin-1-yl)phenyl)boronic acid, 97.0%, 25g